======= PKP1 =======
== Gene Information ==
* **Official Symbol**: PKP1
* **Official Name**: plakophilin 1
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=5317|5317]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q13835|Q13835]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=PKP1&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20PKP1|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/601975|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: This gene encodes a member of the arm-repeat (armadillo) and plakophilin gene families. Plakophilin proteins contain numerous armadillo repeats, localize to cell desmosomes and nuclei, and participate in linking cadherins to intermediate filaments in the cytoskeleton. This protein may be involved in molecular recruitment and stabilization during desmosome formation. Mutations in this gene have been associated with the ectodermal dysplasia/skin fragility syndrome. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2010].
* **UniProt Summary**: Seems to play a role in junctional plaques. Contributes to epidermal morphogenesis. {ECO:0000269|PubMed:9326952}.
|Arm|
|intermediate filament bundle assembly|
|intermediate filament binding|
|messenger ribonucleoprotein complex|
|structural constituent of epidermis|
|lamin binding|
|intermediate filament organization|
|desmosome|
|intermediate filament cytoskeleton organization|
|intermediate filament-based process|
|negative regulation of mRNA catabolic process|
|negative regulation of RNA catabolic process|
|ficolin-1-rich granule membrane|
|cornified envelope|
|negative regulation of mRNA metabolic process|
|cell-cell adherens junction|
|cell-cell junction assembly|
|cornification|
|intermediate filament|
|cell-cell junction organization|
|cell junction assembly|
|cell-cell junction|
|regulation of mRNA catabolic process|
|cell junction organization|
|keratinization|
|negative regulation of cellular catabolic process|
|keratinocyte differentiation|
|negative regulation of catabolic process|
|cadherin binding|
|epidermal cell differentiation|
|regulation of mRNA metabolic process|
|skin development|
|epidermis development|
|supramolecular fiber organization|
|neutrophil degranulation|
|neutrophil activation involved in immune response|
|neutrophil mediated immunity|
|neutrophil activation|
|cell-cell adhesion|
|granulocyte activation|
|leukocyte degranulation|
|myeloid leukocyte mediated immunity|
|myeloid cell activation involved in immune response|
|myeloid leukocyte activation|
|leukocyte activation involved in immune response|
|cell activation involved in immune response|
|epithelial cell differentiation|
|intracellular membrane-bounded organelle|
|regulated exocytosis|
|leukocyte mediated immunity|
|exocytosis|
|regulation of cellular catabolic process|
|leukocyte activation|
|cell adhesion|
|biological adhesion|
|regulation of catabolic process|
|secretion by cell|
|export from cell|
|programmed cell death|
|cell activation|
|immune effector process|
|cell death|
|cytoskeleton organization|
|epithelium development|
|secretion|
|negative regulation of RNA metabolic process|
|negative regulation of nucleobase-containing compound metabolic process|
|tissue development|
|immune response|
|vesicle-mediated transport|
|positive regulation of gene expression|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp65|Mubritinib 0.2μM R02 exp65]]|2.18|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 9097
* **Expression level (log2 read counts)**: -4.27
{{:chemogenomics:nalm6 dist.png?nolink |}}